Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant.
Hiwarkar P, Amrolia P, Sivaprakasam P, Lum SH, Doss H, O'Rafferty C, Petterson T, Patrick K, Silva J, Slatter M, Lawson S, Rao K, Steward C, Gassas A, Veys P, Wynn R; United Kingdom Paediatric Bone Marrow Transplant Group.
Hiwarkar P, et al. Among authors: petterson t.
Blood. 2017 Apr 6;129(14):2033-2037. doi: 10.1182/blood-2016-11-749721. Epub 2017 Feb 2.
Blood. 2017.
PMID: 28153824
Free article.
Clinical Trial.